Researchers at the University of California, Davis, recently discovered new insights into feline infectious peritonitis (FIP). Significantly, they found how FIP can help us better understand human coronaviruses.
The study reveals how FIP spreads through a cat’s immune system and infects a wider range of immune cells than previously believed. This finding provides a valuable model for studying long-term coronavirus disease in humans.
A mutated form of feline coronavirus causes FIP, one of the most devastating infectious diseases in cats. Without treatment, it is almost always fatal. FIP shares striking similarities with severe coronavirus-related conditions in humans. These similarities include widespread inflammation, multi-organ damage, and persistent or recurring symptoms.
For years, scientists believed the FIP virus targeted only one type of immune cell. The study challenged this assumption by examining lymph node samples from cats with naturally occurring FIP.
The researchers found viral material inside multiple immune cell types. Affected cells include B lymphocytes, which produce antibodies, and T lymphocytes, which orchestrate immune defense. Importantly, the virus did not merely appear in these cells — it actively replicated within them.
This broader infection pattern has significant implications. In human medicine, scientists suspect that coronaviruses may persist in immune tissues, contributing to chronic illness or relapse. Cats with FIP provide a rare opportunity to observe these processes in a naturally occurring disease.
The researchers also found that viral traces can remain in immune cells even after antiviral treatment. Cats may seem clinically healthy but still retain these viral traces. Because some immune cells can survive for years, this lingering infection may explain why certain cats relapse or develop long-term immune dysfunction.
These findings position FIP as a valuable comparative model for understanding chronic inflammation and post-viral syndromes, including long COVID in humans.
